Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood pressure and dementia.

W H Birkenhäger1, J A Staessen

  • 1Erasmus University, Rotterdam, the Netherlands.

Panminerva Medica
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

High blood pressure (hypertension) is a key risk factor for dementia, including Alzheimer's disease. Dihydropyridine calcium antagonists show proven value in preventing Alzheimer's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Management Of Hypertension - Back To Square One?

Acta clinica Belgica·2016
Same author

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.

International journal of cardiology·2015
Same author

Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study.

Journal of human hypertension·2014
Same author

The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white Europeans.

Journal of human hypertension·2014
Same author

Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.

Journal of human hypertension·2014
Same author

Do level and variability of systolic blood pressure predict arterial properties or vice versa?

Journal of human hypertension·2013
Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026
Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026
Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026
See all related articles

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Hypertension is a significant risk factor for both vascular and Alzheimer's-type dementias.
  • The development of dementia can occur years or decades after hypertension onset.
  • Blood pressure may decrease before overt Alzheimer's disease manifestation.

Purpose of the Study:

  • To investigate the role of antihypertensive regimens in delaying or preventing dementia.
  • To compare the efficacy of different antihypertensive drug classes for dementia prevention.

Main Methods:

  • Analysis of existing data on hypertension and dementia development.
  • Review of clinical trials, including the Syst-Eur trial.

Main Results:

Related Experiment Videos

  • No comprehensive trials have definitively compared all antihypertensive classes for dementia prevention.
  • Dihydropyridine calcium antagonists, like nitrendipine, are statistically proven to significantly aid in Alzheimer's disease prevention.

Conclusions:

  • The potential of antihypertensive treatment to prevent dementia remains an area requiring further research.
  • Dihydropyridine calcium antagonists represent a promising class for Alzheimer's disease prevention based on current evidence.